These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511 [TBL] [Abstract][Full Text] [Related]
3. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026 [TBL] [Abstract][Full Text] [Related]
4. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999 [TBL] [Abstract][Full Text] [Related]
5. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. van der Meij EH; Mast H; van der Waal I Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770 [TBL] [Abstract][Full Text] [Related]
6. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions. Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients. Nishisaka T; Takeshima Y; Inai K Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577 [TBL] [Abstract][Full Text] [Related]
8. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911 [TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Roz L; Wu CL; Porter S; Scully C; Speight P; Read A; Sloan P; Thakker N Cancer Res; 1996 Mar; 56(6):1228-31. PubMed ID: 8640803 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Acay RR; Felizzola CR; de Araújo N; de Sousa SO Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678 [TBL] [Abstract][Full Text] [Related]
11. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature. Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG J BUON; 2011; 16(4):613-6. PubMed ID: 22331711 [TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa. Guo T; Sun JW; Lv QP; Li XG J Laryngol Otol; 2008 Jan; 122(1):72-7. PubMed ID: 17498326 [TBL] [Abstract][Full Text] [Related]
13. High frequency of allelic loss in dysplastic lichenoid lesions. Zhang L; Cheng X; Li Y; Poh C; Zeng T; Priddy R; Lovas J; Freedman P; Daley T; Rosin MP Lab Invest; 2000 Feb; 80(2):233-7. PubMed ID: 10701692 [TBL] [Abstract][Full Text] [Related]
14. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics. Kim J; Yook JI; Lee EH; Ryu MH; Yoon JH; Hong JC; Kim DJ; Kim HS J Oral Pathol Med; 2001 Feb; 30(2):65-72. PubMed ID: 11168849 [TBL] [Abstract][Full Text] [Related]
16. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233 [TBL] [Abstract][Full Text] [Related]
17. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions. Mattila R; Alanen K; Syrjänen S Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627 [TBL] [Abstract][Full Text] [Related]
20. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]